Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis - ScienceDirect
Neurofilament light chain as a biomarker in neurological disorders | Journal of Neurology, Neurosurgery & Psychiatry
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS | Neurology Neuroimmunology & Neuroinflammation
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy | Diabetologia
Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders | SpringerLink
Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19 - ScienceDirect
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study - The Lancet Neurology
Role of NFL in AD pathogenesis (NFL neurofilament light chain, CSF... | Download Scientific Diagram
Serum Neurofilament Light Chain: A Potential Biomarker for Peripheral Neuropathy | Siriraj Medical Journal
Frontiers | Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Neurofilaments as biomarkers in neurological disorders | Nature Reviews Neurology
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study - The Lancet Neurology
Plasma neurofilament light chain protein as a predictor of days in delirium and deep sedation, mortality and length of stay in critically ill patients - eBioMedicine
Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy | Scientific Reports
Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective | Biomolecules and Biomedicine
Neurofilament Light Chain (NfL) as a Biomarker in Neurological Disorders - YouTube
Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species: Molecular Therapy - Methods & Clinical Development
Neurofilament Light Chain Fact Sheet | Cleveland Clinic
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit - Pratt - 2022 - Journal of Cachexia, Sarcopenia and Muscle - Wiley Online Library
Frontiers | Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study - The Lancet Neurology
Cancers | Free Full-Text | Neurofilament Light Chain as A Biomarker for Brain Metastases
Neurofilament light chain plasma levels are associated with area of brain damage in experimental cerebral malaria | Scientific Reports
Neurofilament Light Chain (NfL)* Testing Service - Siemens Healthineers USA
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome | Journal of Neurology
